Kutluk Oktay, M.D., F.A.C.O.G.

Dr. Oktay is a pioneer in the field of Reproductive Medicine & Infertility and in Fertility Preservation. Dr. Oktay developed and performed the world’s first ovarian transplantation procedures with frozen-banked ovarian tissue and has invented novel ovarian stimulation protocols for cancer patients undergoing embryo and oocyte freezing. Furthermore, he has also developed novel approaches to in vitro fertilization treatments. Dr. Oktay has recently received a $1.6 million research grant from the National Institute of Health to study the impact of chemotherapy on ovarian reserve and was invited to the President’s Cancer Panel as an expert on fertility preservation. Furthermore, he is the co-chair of the American Society of Clinical Oncology Committee for Fertility Preservation Guidelines for People with Cancer. Dr. Oktay has also conducted key work on early stages of ovarian follicle and embryo development, as well as on controlled ovarian stimulation and in vitro fertilization. He has published over 80 articles and book chapters, continuously lectures around the world, and has been recognized with numerous prestigious scientific and clinical awards.

Dr. Oktay’s research has attracted significant publicity and has been covered by the press around the world. He has been named among the top Doctors of the country and in NY metropolitan area repeatedly. Dr. Oktay states “I enjoy being able to transfer the information I gained from the bench research as well as the clinical studies that I am performing for the care of my everyday patients. It is extremely difficult to be a researcher, clinician, and an accomplished surgeon at once but the rewards justify the effort.”

Download Dr. Oktay's Curriculum Vitae

[ Back to top ]

Norbert Gleicher, M.D., F.A.C.O.G., F.A.C.S.

Dr. Norbert Gleicher founded the Center for Human Reproduction (CHR) in 1981. He is a graduate of Tel Aviv Medical School, Israel, and completed his residency at the Mount Sinai School of Medicine in New York. Dr. Gleicher was appointed to the facility as an Assistant Professor in charge of student and resident education in Obstetrics and Gynecology, and became Chief of the Section for Reproductive Immunology. Two years later, he moved to Chicago when he was offered the position of Chairman of Obstetrics and Gynecology at the Mount Sinai Hospital Medical Center, Professor of Obstetrics and Gynecology and Associate Professor of Immunology/Microbiology at Rush Medical College. He held his position as Chairman for 10 years, until his resignation in 1990. Since then, he has held a variety of academic and administrative positions. Dr. Gleicher is currently Medical Director of CHR-New York and a Visiting Professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at Yale University School of Medicine in New Haven, Connecticut.

Dr. Gleicher has published hundreds of peer-reviewed scientific papers, abstracts and book chapters in the areas of reproductive endocrinology and infertility, as well as in areas of medical complications in pregnancy. He has edited some of the most prestigious textbooks in these specialties and has served as the Editor-in-Chief for the American Journal of Reproductive Immunology and Microbiology and the Journal of In Vitro Fertilization and Embryo Transfer, which was renamed the Journal of Assisted Reproduction and Genetics in 1992.

Dr. Gleicher serves as ad hoc reviewer and editorial board member for many other medical journals. He is a Fellow of the American College of Obstetricians and Gynecologists and, in addition to many other societies and professional organizations, a member of the American Society for Reproductive Medicine (ASRM) and the European Society of Human Reproduction and Embryology (ESHRE). He was chosen by Chicago magazine and other organizations as being amongst the ‘best physicians’ in reproductive endocrinology and infertility, as well as obstetrics and gynecology, as designated by his peers.

Dr. Gleicher now practices exclusively in New York City, although he still consults with CHR’s Chicago practices.

Dr. Gleicher speaks German, Hebrew and Polish.

Download Dr. Gleicher's Curriculum Vitae

[ Back to top ]

David Barad, M.D., M.S., F.A.C.O.G.

Dr. Barad has been increasingly active in clinical research. He served as an investigator at the New York Clinical Center of the Women’s Health Initiative (WHI) on the landmark study examining factors that may affect the health of women after menopause. He is currently a scientific consultant for the WHI, and is presently Chair of the WHI Hormone Trials advisory committee. Dr. Barad also serves on many national and international WHI committees.

Dr. Barad has published extensively in the field of Reproductive Endocrinology. He is a fellow of the American College of Obstetrics and Gynecology, a member of the American Society of Reproductive Medicine and of the Society of Reproductive Endocrinology, as well as numerous other professional societies and organizations.

In May 2003 Dr. Barad was awarded a Masters of Science degree in Clinical Research Methods at the Albert Einstein College of Medicine. In 1999 he was recognized by the American Infertility Association for his “continuing dedication and support to individuals experiencing infertility.”

Download Dr. Barad's Curriculum Vitae

[ Back to top ]